2025 SOA ImpACT Conference:Session 4G: GLP-1s and the Holistic ROI of Obesity Intervention-11.04.25 Recording

As obesity rates continue to rise globally, the health, economic, and societal consequences have become impossible to ignore. It's become one of the biggest public health challenges we face-driving up healthcare costs, increasing rates of chronic illness, and taking a toll on workforce productivity. To address this growing crisis, innovative tools and interventions are required-both to manage obesity more effectively and to demonstrate the return on investment (ROI) of such strategies to healthcare stakeholders. Come explore the impact of GLP-1s and how an ROI 'Value Stack' can help stakeholders understand their full impact. Discover how obesity affects health outcomes, longevity, and healthcare costs-and how GLP-1s can reduce body mass index (BMI) and mitigate chronic disease risks. Through data analysis, peer-reviewed research, and scenario modeling, we explore the value and costs of GLP-1s, including pharmacy and adverse event costs, medical cost offsets, productivity gains, and broader societal benefits such as reduced caregiver burden. We'll also examine how factors like adherence, patient demographics, and disease burden influence ROI outcomes. Attendees will be able to: - Understand the magnitude of the obesity crisis and its impact on health systems. - Learn about the economic rationale for GLP-1s, observed outcomes in reducing comorbidities. - Explore how stakeholder ROI models can quantify the value of GLP-1 interventions for healthcare systems and society. - Discover practical applications of the Value Stack model, including segment-specific projections, ROI components, and key assumptions.